Incyte (INCY) Current Deferred Revenue (2010 - 2016)

Incyte's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $2.9 million for Q3 2016.

• Quarterly Current Deferred Revenue fell 77.69% year-over-year to $2.9 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $2.9 million (down 77.69% YoY) and the FY2015 annual result came in at $12.5 million, down 2.86% from the prior year.
• Current Deferred Revenue was $2.9 million for Q3 2016 at Incyte, down from $6.1 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $67.0 million in Q1 2012 and bottomed at $2.9 million in Q3 2016.
• A 5-year average of $27.3 million and a median of $12.9 million in 2014 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2012 — Current Deferred Revenue changed 0.0% — and 2013, when it tumbled 80.49%.
• Incyte's Current Deferred Revenue stood at $66.1 million in 2012, then tumbled by 80.49% to $12.9 million in 2013, then dropped by 0.08% to $12.9 million in 2014, then fell by 2.86% to $12.5 million in 2015, then plunged by 77.08% to $2.9 million in 2016.
• Business Quant data shows INCY's Current Deferred Revenue at $2.9 million in Q3 2016, $6.1 million in Q2 2016, and $9.3 million in Q1 2016.